文献速递遗传性与小管间质肾病慢性肾脏病

土耳其胱氨酸贮积症患者的临床与突变谱

The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-08-09

该多中心注册研究纳入136例土耳其儿童胱氨酸贮积症患者,分析其临床特征和CTNS基因突变谱。最常见突变为c.681G>A(31%)、c.1015G>A(22%)和c.18_21 del(14%),均与发病年龄更早相关;未发现57-kb缺失,发现7个新突变。2岁前开始治疗者ESRD发生更晚(P=0.02),错义突变患者末次随访eGFR较好但差异无统计学意义。

要点

  • 土耳其儿童胱氨酸贮积症最常见突变为c.681G>A、c.1015G>A和c.18_21 del。
  • 上述常见突变与发病年龄更早相关,未发现57-kb缺失。
  • 2岁前开始治疗可延迟ESRD发生(P=0.02)。

核心结论

  • 土耳其胱氨酸贮积症最常见突变为c.681G>A(p.Glu227Glu)、c.1015G>A(p.Gly339Arg)和c.18_21 del(p.Thr7Phefs*7)。
  • 较不严重的CTNS基因突变患者倾向于有更好的肾脏结局。

研究设计与样本

  • 多中心注册研究,纳入136例土耳其儿童胱氨酸贮积症患者(75男,61女),提取注册数据进行分析。

主要发现

  • 最常见临床表现为生长迟缓、多尿和食欲丧失。
  • 未发现57-kb缺失,发现7个新突变。
  • c.681G>A(31%)、c.1015G>A(22%)和c.18_21 del(14%)与发病年龄更早相关。
  • 错义突变患者末次随访eGFR较好,但差异无统计学意义。
  • 2岁前开始治疗者ESRD发生更晚(P=0.02);两组突变类型间ESRD时间无差异。

关键数值与推荐

  • c.681G>A(p.Glu227Glu)频率31%,c.1015G>A(p.Gly339Arg)频率22%,c.18_21 del(p.Thr7Phefs*7)频率14%。
  • 2岁前开始治疗与ESRD发生更晚相关(P=0.02)。

临床怎么用

  • 对土耳其儿童胱氨酸贮积症患者应关注常见突变类型,2岁前开始治疗可能延迟ESRD。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Infantile nephropathic cystinosis is a severe disease that occurs due to mutations in the cystinosis gene, and it is characterized by progressive dysfunction of multiple organs; >100 cystinosis gene mutations have been identified in multiple populations. Our study aimed to identify the clinical characteristics and spectrum of cystinosis gene mutations in Turkish pediatric patients with cystinosis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We identified the clinical characteristics and spectrum of cystinosis gene mutations in Turkish patients with cystinosis in a multicenter registry that was established for data collection. The data were extracted from this registry and analyzed. RESULTS: In total, 136 patients (75 men and 61 women) were enrolled in the study. The most common clinical findings were growth retardation, polyuria, and loss of appetite. None of the patients had the 57-kb deletion, but seven novel mutations were identified. The most common mutations identified were c.681G>A (p.Glu227Glu; 31%), c.1015G>A (p.Gly339Arg; 22%), and c.18_21 del (p.Thr7Phefs*7; 14%). These mutations were associated with earlier age of disease onset than the other mutations. To understand the effects of these allelic variants on clinical progression, the mutations were categorized into two major groups (missense versus deletion/duplication/splice site). Although patients with missense mutations had a better eGFR at the last follow-up visit, the difference was not significant. Patients in whom treatment began at age <2 years old had later onset of ESRD (P=0.02). Time to ESRD did not differ between the patients with group 1 and group 2 mutations. CONCLUSIONS: The most common cystinosis gene mutations identified in Turkey were c.681G>A (p.Glu227Glu), c.1015G>A (p.Gly339Arg), and c.18_21 del (p.Thr7Phefs*7). Patients with less severe cystinosis gene mutations tend to have better kidney outcome.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Topaloglu R, Gulhan B, İnözü M, et al. The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis. Clin J Am Soc Nephrol. 2017. PMID: 28793998. doi:10.2215/CJN.00180117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。